The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person

The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person

Meletios Verras/ iStock

The FDA approved the first gene therapy treatments for sickle cell disease on Friday, but it will cost patients millions of dollars.

0

No comments

Read more